Correction

The article ‘Type 2 diabetes in youth – a growing concern’ by Dr Uma Ganti, which was published in the November 2025 issue of Endocrinology Today (pages 58 to 67), contains an error. On page 66, the TGA stance on dapagliflozin use in people aged under 18 years is incorrect, and it should state: ‘Although the TGA has not approved dapagliflozin for use in children and adolescents (because of limited paediatric data), small pharmacokinetic and pharmacodynamic studies in youth suggest characteristics similar to adults. Safety and tolerability data are reassuring, but larger and longer-term paediatric studies remain needed.’

We apologise for this oversight and any confusion it may have caused. The online version and full-text PDF of this article are correct at: https://endocrinology.medicinetoday.com.au/et/2025/november/feature-article/type-2-diabetes-youth-growing-concern.